Plain-English translation of NCT06975787 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This research study is testing two experimental medications called and for treating lupus nephritis — a condition where lupus damages the kidneys. Researchers want to understand how safe these medications are, what side effects might occur, and how they work in the body over time.
Lupus nephritis can be hard to treat, especially when it keeps coming back or doesn't respond to standard treatments. This trial exists to explore whether these new antibody medications might offer patients with harder-to-treat disease a better option.
You likely qualify if…
You likely don't qualify if…
You would receive the study medication for a short period and then be monitored closely over time. The study involves blood tests to check how much medication is in your system, whether your body develops antibodies against it, and what side effects might occur. You'll have follow-up visits to track your kidney function and overall response to the treatment.
AI-generated summary from trial data · Sep 15, 2026 · Not medical advice
United States
France
Germany